title: [Value of a new thickened formula in infants with regurgitations].
abstract: OBJECTIVE
  The purpose of this open multicenter study was to evaluate the value of a new starch-thickened formula in infants with regurgitations in ambulatory pediatric practice.
  
  
  METHODS
  The study population comprised full-term infants with an age at inclusion of 1-90 days, who were bottle-fed and presented regurgitations. The formula tested was an infant formula-thickened with starch (2g/100mL). The primary endpoint was the frequency of bottles regurgitated, expressed in percentage of meals per day after 15 days of feeding with the preparation studied. Secondary endpoints were the assessment of regurgitations using the Vandenplas' score, as well as the daily increase in weight, height, and cranial circumference, overall and gastrointestinal tolerance, and formula acceptability.
  
  
  RESULTS
  Sixty-four infants presenting regurgitation were included. The frequency of bottles regurgitated estimated at 80.3% at inclusion significantly decreased at D3, D15, and D30 to 40.1, 40.2 and 37.2% (P<0.0001), respectively. Thirty percent of infants did not present regurgitations at all at D30. Similarly, a significant decrease in the Vandenplas' score was observed from 1.9 at D0 to 0.9 at D30 (P<0.0001). Infant growth was similar to the French and European growth curves.
  
  
  CONCLUSIONS
  The results showed rapid and lasting improvement in decreasing the frequency of feeding-bottles regurgitated by 50% from the first 3 days of using this new starch-thickened formula (2g/100mL). These satisfying results encourage the use of the tested formula in cases of infant regurgitation, in line with the European Society of Gastroenterology, Hepatology and Nutrition (ESPGHAN) recommendations.
authors.affiliation: Service de pédiatrie, hôpital Ambroise-Paré, 92100 Boulogne-Billancourt, France. bertrand.chevallier@apr.aphp.fr
authors.forename: B
authors.initials: B
authors.lastname: Chevallier
authors.forename: V
authors.initials: V
authors.lastname: Fournier
authors.forename: B
authors.initials: B
authors.lastname: Logre
authors.forename: L
authors.initials: L
authors.lastname: Beck
authors.forename: F
authors.initials: F
authors.lastname: Ceccato
authors.forename: G
authors.initials: G
authors.lastname: Hui Bon Hoa
authors.forename: E
authors.initials: E
authors.lastname: Lachambre
authors.forename: L-D
authors.initials: LD
authors.lastname: Van Egroo
authors.forename: M
authors.initials: M
authors.lastname: Sznajder
mesh_terms: D015331:Cohort Studies; D005260:Female; D005764:Gastroesophageal Reflux / Q000517:prevention & control*; D006801:Humans; D007223:Infant; D041943:Infant Formula / Q000008:administration & dosage / Q000737:chemistry*; D007231:Infant, Newborn; D008297:Male; D013213:Starch / Q000032:analysis*; D014839:Vomiting / Q000517:prevention & control
chemical_list: D013213:Starch